Navigation Links
New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
Date:11/6/2012

n patients whose tumours express Fn14 might prevent cancer cells from growing and proliferating."

Fn14 is over-expressed in at least 30% of several solid tumours, including pancreatic cancer, breast cancer, non-small cell lung cancer and malignant melanoma.

From July 2011, Dr Lassen and his colleagues recruited 38 patients with treatment-refractory solid tumours to the phase I trial. All patients had tumours expressing the Fn14 receptor. They received an intravenous dose of the drug either once weekly or once every three weeks, with a dose range of 200 to 3600 mg.

Dr Lassen said: "Several of the patients continue to receive study treatments, and encouraging signs of clinical benefit have already been observed. A patient with heavily pre-treated, metastatic melanoma with no mutation in the BRAF gene has shown evidence of tumour regression when scanned using computerised tomography (CT) and remains on study after more than 30 weeks of treatment. Four other patients have had partial metabolic responses confirmed by positron emission tomography (PET) scans.

"Prolonged stable disease has been seen in several patients. Overall, 11 of the 38 patients (29%) have received more than 12 weeks of study treatment, with several receiving 18 or more weeks of RG7212 therapy, including those with refractory NSCLC, melanoma, mesothelioma, breast cancer, renal cell carcinoma, and biliary tract cancer.

"We found that RG7212 has an excellent safety profile across a broad dose range on each schedule. We saw no dose-limiting toxicities and no patient discontinued study treatments for treatment-related adverse side-effects. The phase I data show that RG7212 is quite safe for multi-cycle administration in patients with advanced cancer. Results from tests of blood and tumour samples suggest that it would be feasible to administer the drug over a prolonged period of time.

"There are encouraging pharmacodynamic data (effects of the drug on
'/>"/>

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Elevated Antibody Levels May Predict Rheumatoid Arthritis Risk
2. NIH scientists map first steps in flu antibody development
3. Scientists Pinpoint Antibody That May Be Specific to MS Patients
4. Antibody therapy prevents gastrointestinal damage following radiation exposure in mice
5. Molecule found that inhibits recovery from stroke
6. Bloodstream scavenger inhibits clotting without increased bleeding
7. Laser-light testing of breast tumor fiber patterns helps show whose cancer is spreading
8. IU researchers report first effective treatment of tumors arising from common genetic disease NF1
9. Quality of Life After Cancer May Depend on Tumor Type
10. Socioeconomic disadvantage linked to breast cancer tumor disparity
11. Minorities most likely to have aggressive tumors, less likely to get radiation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 19, 2014 (HealthDay News) -- U.S. and state health ... apples that has killed at least four people and ... not eat any commercially produced, prepackaged caramel apples until ... Control and Prevention said in a news release. ... had been infected with the outbreak strains of the ...
(Date:12/22/2014)... OH (PRWEB) December 22, 2014 Explorys, ... three additions to its leadership team: Greg Yarrington as ... of Engineering, and Patrick Wells as Vice President of ... to add 80 new jobs in 2015 to support ... expansion of its platform-as-a-service offerings, and growth of its ...
(Date:12/22/2014)... Pasadena, CA (PRWEB) December 22, 2014 ... is now offering consultations for sleep apnea. Drowsy drivers ... crashes than drivers who are well-rested, and some experts ... on the roads as intoxicated drivers. Unfortunately, millions of ... to the American Academy of Sleep Medicine, about 18 ...
(Date:12/22/2014)... 22, 2014 Christmas is days away, and ... fast and easy solution that will please: the Sublime ... purchased from from $25 up to $350," says Kathy Heshelow, ... satisfaction and a wide array of skin care products and ... no expiration dates. , Gift delivery past shipping deadlines, ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 At ... Conference, next month in San Antonio, esteemed ... address dynamics that often stand in the way ... competition. , This premier faculty development opportunity ... Transformational Leadership, whose mission is to assist nurse ...
Breaking Medicine News(10 mins):Health News:CDC Warns of Listeria Danger From Caramel Apples 2Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 2Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 3Health News:Pasadena Dentist, Dr. Marine Martirosyan, Now Offers Consultations for Sleep Apnea 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 3
... ... in the parts washing industry. Midbrook has extensive experience washing parts and equipment in a ... Washing facility to help a North American automotive parts supplier solve a de-rusting issue. ... (Vocus) October 6, 2009 -- ...
... ... important factors when selecting a Medicare plan , ... Belleville, Ill. (Vocus) – People with disabilities have crucial ... , a nationwide provider of Social Security disability representation and Medicare services. , ...
... ... Faculty Investigator, made major discoveries in telomere biochemistry and regulation , ... Cold Spring Harbor, NY (Vocus) October ... has been named a Nobel Laureate, Cold Spring Harbor Laboratory President Bruce Stillman said, ...
... ... Securities Exchange-listed oncology biotechnology company, announced today an AU$7,230,000 investment by SpringTree Special ... financial advisor to SpringTree,s general partner SpringTree Global Investors, LLC on the transaction. ... ...
... , YORKTOWN HEIGHTS, N.Y., Oct. 6 In an effort to ... ) scientists are drilling nano-sized holes in computer-like chips and passing ... within their genetic code. , View video: ... , For an ongoing conversation on ...
... NEWNAN, Ga., Oct. 6 The authors of ... Vascular Disease Management conclude that the micro-bland embolization ... better clinical outcomes. Franco Orsi, MD, PhD, and ... in Rome conclude that small, tightly calibrated Embozene(TM) ...
Cached Medicine News:Health News:Midbrook Production Washing A Valuable Partner 2Health News:Midbrook Production Washing A Valuable Partner 3Health News:People with Disabilities Face Unique Healthcare Coverage Challenges, Allsup Says 2Health News:People with Disabilities Face Unique Healthcare Coverage Challenges, Allsup Says 3Health News:People with Disabilities Face Unique Healthcare Coverage Challenges, Allsup Says 4Health News:People with Disabilities Face Unique Healthcare Coverage Challenges, Allsup Says 5Health News:People with Disabilities Face Unique Healthcare Coverage Challenges, Allsup Says 6Health News:Cold Spring Harbor Laboratory's President Congratulates Alumna on Winning Nobel Prize 2Health News:KTA Capital Advises SpringTree Global Investors on an AU$7.2 Million Investment in HealthLinx Ltd 2Health News:IBM Research Aims to Build Nanoscale DNA Sequencer to Help Drive Down Cost of Personalized Genetic Analysis 2Health News:IBM Research Aims to Build Nanoscale DNA Sequencer to Help Drive Down Cost of Personalized Genetic Analysis 3Health News:IBM Research Aims to Build Nanoscale DNA Sequencer to Help Drive Down Cost of Personalized Genetic Analysis 4Health News:Scientific Paper Supports Micro-Bland Embolization Technique for Liver Cancer With Embozene(TM) Microspheres 2
(Date:12/22/2014)... a privately-held medical products and technologies company, today announced ... Officer of the company, effective December 22, 2014. ... Board of Directors of ConvaTec thanks Mr. Berger for ... years," said Magnus Lundberg , the Chairman of ... company is well positioned for the future."  The company ...
(Date:12/22/2014)... Dec. 22, 2014  Mark Farrah Associates (MFA), ... a summary of the 2015 marketplace exchange projections ... According to a recent ASPE ... Evaluation, Department of Health and Human Services) report, ... individual medical plans through the Marketplace as of ...
(Date:12/22/2014)... , Dec. 22, 2014 TWi Biotechnology, ... of Allowance for AC-201, TWi Biotechnology,s lead drug ... China for patent application ... pharmaceutically acceptable salts, active metabolite for treatment of ... methods of treatment using AC-201 for type II ...
Breaking Medicine Technology:ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2Insights into the Marketplace and Individual Market Growth 2TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 2TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 3
... Oct. 3, 2011 To help frustrated nighttime nasal ... chronic nasal congestion and trouble with sleep, the makers ... to identify the 20 Most Congested Cities in the ... metropolitan areas where residents are most challenged by congestion ...
... MURRIETA, Calif., Oct. 3, 2011 ... recently took delivery of their long-awaited WASP® (Walk ... Module.  The acquisition was concomitant with the inauguration ... ongoing efforts to optimize patient care by consolidating ...
Cached Medicine Technology:20 Most Congested Cities in U.S. Unveiled 220 Most Congested Cities in U.S. Unveiled 320 Most Congested Cities in U.S. Unveiled 4COPAN WASP® Lands at Prestigious Boston Medical Center 2COPAN WASP® Lands at Prestigious Boston Medical Center 3
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: